Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors

NCT01719861 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Lack of efficacy

Conditions

Small Cell Lung Cancer (SCLC)
Neuroendocrine Tumors

Interventions

DRUG: Desipramine HCL

Sponsor

Joel Neal